---
$id: https://graph.org.ai/products/commodity/51131908
$type: Product
source: UNSPSC
code: "51131908"
title: "Hetastarch"
class: "51131900"
classTitle: "Blood plasma substitutes and extenders and expanders"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hetastarch

**UNSPSC Code**: 51131908
**Class**: [Blood plasma substitutes and extenders and expanders](Blood plasma substitutes and extenders and expanders.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a blood substitute, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 875Y4127EA. European Medicines Agency schedules Hetastarch in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14097MIG. Hetastarch generally arises in the molecular formula (C6H7O5)N.C2H5O.H. The term 'hetastarch' is an FDA designation. As of Q4 2014, HETASTARCH remains the US FDA Preferred Term for this commodity. Hetastarch bears US NLM identifiers UMLS ID C0020352 and NCI Concept Code C559. SMILES: CC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)OC)O)O)OC4C(C(C(C(O4)CO)OC)O)OCCO)O)O)O)O.

